vs
ExlService Holdings, Inc.（EXLS）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ExlService Holdings, Inc.的季度营收约是ICU MEDICAL INC的1.0倍（$542.6M vs $540.7M），ExlService Holdings, Inc.净利率更高（11.1% vs -2.9%，领先14.0%），ExlService Holdings, Inc.同比增速更快（12.7% vs -14.1%），ExlService Holdings, Inc.自由现金流更多（$106.5M vs $36.0M），过去两年ExlService Holdings, Inc.的营收复合增速更高（11.5% vs -2.3%）
ExlService Holdings Inc.是全球知名的分析与数字解决方案服务商，服务覆盖保险、医疗健康、银行金融服务、媒体、零售等多个行业，总部位于纽约，在美国、欧洲、亚洲、拉美、澳大利亚、南非等地拥有超过5.4万名专业从业人员。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
EXLS vs ICUI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $542.6M | $540.7M |
| 净利润 | $60.2M | $-15.7M |
| 毛利率 | 38.6% | 37.5% |
| 营业利润率 | 14.4% | 1.0% |
| 净利率 | 11.1% | -2.9% |
| 营收同比 | 12.7% | -14.1% |
| 净利润同比 | 18.9% | 34.0% |
| 每股收益（稀释后） | $0.38 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $542.6M | $540.7M | ||
| Q3 25 | $529.6M | $537.0M | ||
| Q2 25 | $514.5M | $548.9M | ||
| Q1 25 | $501.0M | $604.7M | ||
| Q4 24 | $481.4M | $629.8M | ||
| Q3 24 | $472.1M | $589.1M | ||
| Q2 24 | $448.4M | $596.5M | ||
| Q1 24 | $436.5M | $566.7M |
| Q4 25 | $60.2M | $-15.7M | ||
| Q3 25 | $58.2M | $-3.4M | ||
| Q2 25 | $66.1M | $35.3M | ||
| Q1 25 | $66.6M | $-15.5M | ||
| Q4 24 | $50.7M | $-23.8M | ||
| Q3 24 | $53.0M | $-33.0M | ||
| Q2 24 | $45.8M | $-21.4M | ||
| Q1 24 | $48.8M | $-39.5M |
| Q4 25 | 38.6% | 37.5% | ||
| Q3 25 | 38.5% | 37.4% | ||
| Q2 25 | 37.7% | 37.9% | ||
| Q1 25 | 38.6% | 34.7% | ||
| Q4 24 | 38.1% | 36.1% | ||
| Q3 24 | 37.8% | 34.8% | ||
| Q2 24 | 37.1% | 34.8% | ||
| Q1 24 | 37.4% | 32.7% |
| Q4 25 | 14.4% | 1.0% | ||
| Q3 25 | 14.4% | 2.6% | ||
| Q2 25 | 15.8% | 1.9% | ||
| Q1 25 | 15.7% | 2.1% | ||
| Q4 24 | 14.8% | 6.0% | ||
| Q3 24 | 14.7% | 1.4% | ||
| Q2 24 | 13.7% | 1.3% | ||
| Q1 24 | 14.1% | -1.9% |
| Q4 25 | 11.1% | -2.9% | ||
| Q3 25 | 11.0% | -0.6% | ||
| Q2 25 | 12.8% | 6.4% | ||
| Q1 25 | 13.3% | -2.6% | ||
| Q4 24 | 10.5% | -3.8% | ||
| Q3 24 | 11.2% | -5.6% | ||
| Q2 24 | 10.2% | -3.6% | ||
| Q1 24 | 11.2% | -7.0% |
| Q4 25 | $0.38 | $-0.63 | ||
| Q3 25 | $0.36 | $-0.14 | ||
| Q2 25 | $0.40 | $1.43 | ||
| Q1 25 | $0.40 | $-0.63 | ||
| Q4 24 | $0.31 | $-0.97 | ||
| Q3 24 | $0.33 | $-1.35 | ||
| Q2 24 | $0.28 | $-0.88 | ||
| Q1 24 | $0.29 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $328.4M | — |
| 总债务越低越好 | $298.6M | — |
| 股东权益账面价值 | $912.7M | $2.1B |
| 总资产 | $1.7B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
| Q4 25 | $328.4M | — | ||
| Q3 25 | $390.1M | — | ||
| Q2 25 | $353.3M | — | ||
| Q1 25 | $331.4M | — | ||
| Q4 24 | $340.6M | $308.6M | ||
| Q3 24 | $325.8M | $312.5M | ||
| Q2 24 | $276.1M | $302.6M | ||
| Q1 24 | $246.2M | $251.4M |
| Q4 25 | $298.6M | — | ||
| Q3 25 | $354.8M | — | ||
| Q2 25 | $260.0M | — | ||
| Q1 25 | $307.3M | — | ||
| Q4 24 | $288.5M | — | ||
| Q3 24 | $344.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $912.7M | $2.1B | ||
| Q3 25 | $952.4M | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $1.0B | $2.0B | ||
| Q4 24 | $929.9M | $2.0B | ||
| Q3 24 | $907.6M | $2.0B | ||
| Q2 24 | $852.6M | $2.0B | ||
| Q1 24 | $803.3M | $2.1B |
| Q4 25 | $1.7B | $4.1B | ||
| Q3 25 | $1.7B | $4.1B | ||
| Q2 25 | $1.7B | $4.1B | ||
| Q1 25 | $1.7B | $4.2B | ||
| Q4 24 | $1.6B | $4.2B | ||
| Q3 24 | $1.6B | $4.3B | ||
| Q2 24 | $1.5B | $4.3B | ||
| Q1 24 | $1.4B | $4.3B |
| Q4 25 | 0.33× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $117.4M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | $106.5M | $36.0M |
| 自由现金流率自由现金流/营收 | 19.6% | 6.6% |
| 资本支出强度资本支出/营收 | 2.0% | 4.6% |
| 现金转化率经营现金流/净利润 | 1.95× | — |
| 过去12个月自由现金流最近4个季度 | $298.1M | $91.8M |
8季度趋势，按日历期对齐
| Q4 25 | $117.4M | $60.6M | ||
| Q3 25 | $120.7M | $56.7M | ||
| Q2 25 | $109.4M | $11.2M | ||
| Q1 25 | $3.2M | $51.3M | ||
| Q4 24 | $105.3M | $40.2M | ||
| Q3 24 | $110.1M | $36.1M | ||
| Q2 24 | $74.9M | $82.0M | ||
| Q1 24 | $-21.9M | $45.8M |
| Q4 25 | $106.5M | $36.0M | ||
| Q3 25 | $106.4M | $27.6M | ||
| Q2 25 | $95.0M | $-8.5M | ||
| Q1 25 | $-9.7M | $36.7M | ||
| Q4 24 | $95.3M | $16.1M | ||
| Q3 24 | $97.3M | $16.2M | ||
| Q2 24 | $62.8M | $62.5M | ||
| Q1 24 | $-33.1M | $29.9M |
| Q4 25 | 19.6% | 6.6% | ||
| Q3 25 | 20.1% | 5.1% | ||
| Q2 25 | 18.5% | -1.5% | ||
| Q1 25 | -1.9% | 6.1% | ||
| Q4 24 | 19.8% | 2.6% | ||
| Q3 24 | 20.6% | 2.7% | ||
| Q2 24 | 14.0% | 10.5% | ||
| Q1 24 | -7.6% | 5.3% |
| Q4 25 | 2.0% | 4.6% | ||
| Q3 25 | 2.7% | 5.4% | ||
| Q2 25 | 2.8% | 3.6% | ||
| Q1 25 | 2.6% | 2.4% | ||
| Q4 24 | 2.1% | 3.8% | ||
| Q3 24 | 2.7% | 3.4% | ||
| Q2 24 | 2.7% | 3.3% | ||
| Q1 24 | 2.6% | 2.8% |
| Q4 25 | 1.95× | — | ||
| Q3 25 | 2.08× | — | ||
| Q2 25 | 1.66× | 0.32× | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 2.08× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | -0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
